BioSig Secures $1.1 Billion Funding for Commodity Tokenization

BioSig Technologies, Inc. has completed a merger with Streamex Exchange Corporation, securing up to $1.1 billion in funding from institutional investors. This significant financial backing is aimed at accelerating the tokenization of commodities, particularly in the $142 trillion commodity market, with a focus on enhancing liquidity and transparency.

The merger represents a strategic shift for BioSig, which was previously focused on medical technology. The collaboration with Streamex, a firm dedicated to the tokenization of real-world assets, marks a transformative opportunity for both companies. The funding package includes $100 million in senior secured convertible debentures and $1 billion in equity financing, providing BioSig with a robust financial foundation to pursue its strategic initiatives. The first $75 million of this funding is expected to be deployed by October 2025.

This merger and funding are part of a broader trend in the financial industry, where entities are increasingly exploring the tokenization of real-world assets. The collaboration between BioSig and Streamex is poised to advance blockchain-based commodity trading, encouraging broader regulatory discussions about digital assets. The gold-backed treasury model, in particular, offers a unique value proposition by combining the stability of gold with the efficiency of blockchain technology.

The transaction is led by a prominent financial services firm, underscoring the credibility and potential of BioSig's new direction. The merger and funding are expected to fuel BioSig's expansion into new markets and accelerate the development of its tokenization platform. This strategic move positions BioSig as a leader in the emerging field of gold-backed blockchain finance, poised to disrupt traditional financial models and create new opportunities for investors and stakeholders alike.